Trial intelligence / Profile preview

Vardenafil crossover trial for erectile dysfunction in men with multiple sclerosis

2004-003761-33Phase 4Completed

Sponsor
Unidad de Neuroinmunología (Hospital Clínic de Barcelona)
Start
Jan 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of vardenafil in erectile dysfunction (ED) (2 arms), sponsored by Unidad de Neuroinmunología (Hospital Clínic de Barcelona). Primary endpoint: IIEF erectile function domain score. Started Jan 2006; status: completed.

02

Drugs

vardenafil
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on 2004-003761-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-003761-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call